AstraZeneca PLC
1452.00
23-十二月-24 10:24:56
15 分钟延时
股票
+23.00
+1.61%
今日范围
1437.00 - 1458.00
ISIN
N/A
来源
Cboe
-
AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines
21 5月 2024 02:02:29 条件 NASDAQ US Markets
-
AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
20 5月 2024 01:42:36 条件 NASDAQ US Markets
-
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
19 5月 2024 21:05:22 条件 NASDAQ US Markets
-
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
16 5月 2024 02:51:29 条件 NASDAQ US Markets
-
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
08 5月 2024 04:10:43 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 4月 2024 02:15:01 条件 NetDania Notify
-
AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer
29 4月 2024 01:45:52 条件 NASDAQ US Markets
-
AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer
29 4月 2024 01:45:52 条件 NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 4月 2024 11:52:49 条件 NASDAQ US Markets
-
25 4月 2024 10:30:48 条件 NASDAQ US Markets
-
25 4月 2024 10:15:48 条件 NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 4月 2024 02:16:35 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 4月 2024 02:15:24 条件 NetDania Notify
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 4月 2024 02:37:17 条件 NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 4月 2024 21:16:14 条件 NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 4月 2024 08:38:12 条件 NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 4月 2024 09:15:53 条件 NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 3月 2024 17:07:03 条件 NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 3月 2024 02:55:20 条件 NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 3月 2024 13:32:29 条件 NASDAQ Stocks